phentermine hydrochloride

Generic: phentermine hydrochloride

Labeler: tagi pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name phentermine hydrochloride
Generic Name phentermine hydrochloride
Labeler tagi pharma, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

phentermine hydrochloride 37.5 mg/1

Manufacturer
TAGI Pharma, Inc.

Identifiers & Regulatory

Product NDC 51224-101
Product ID 51224-101_bcfc205c-6118-4764-8734-efb2bd6f5308
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200272
DEA Schedule civ
Marketing Start 2011-03-08
Marketing End 2028-04-30

Pharmacologic Class

Classes
appetite suppression [pe] increased sympathetic activity [pe] sympathomimetic amine anorectic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51224101
Hyphenated Format 51224-101

Supplemental Identifiers

RxCUI
803353
UPC
0351224101708
UNII
0K2I505OTV

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phentermine hydrochloride (source: ndc)
Generic Name phentermine hydrochloride (source: ndc)
Application Number ANDA200272 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 37.5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (51224-101-50)
  • 1000 TABLET in 1 BOTTLE (51224-101-70)
source: ndc

Packages (2)

Ingredients (1)

phentermine hydrochloride (37.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bcfc205c-6118-4764-8734-efb2bd6f5308", "openfda": {"upc": ["0351224101708"], "unii": ["0K2I505OTV"], "rxcui": ["803353"], "spl_set_id": ["1993b181-f4f1-4451-92a0-7ed8f32598ba"], "manufacturer_name": ["TAGI Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51224-101-50)", "package_ndc": "51224-101-50", "marketing_end_date": "20280430", "marketing_start_date": "20110308"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (51224-101-70)", "package_ndc": "51224-101-70", "marketing_end_date": "20280430", "marketing_start_date": "20110308"}], "brand_name": "Phentermine Hydrochloride", "product_id": "51224-101_bcfc205c-6118-4764-8734-efb2bd6f5308", "dosage_form": "TABLET", "pharm_class": ["Appetite Suppression [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "51224-101", "dea_schedule": "CIV", "generic_name": "Phentermine Hydrochloride", "labeler_name": "TAGI Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phentermine Hydrochloride", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "37.5 mg/1"}], "application_number": "ANDA200272", "marketing_category": "ANDA", "marketing_end_date": "20280430", "marketing_start_date": "20110308"}